BAY88-8223, Does Response Study in HRPC Patients

Clinical trial NCT00667199 · COMPLETED

Trial details

NCT number: NCT00667199
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer Bone Metastases

Start date: 2005-05-30
Primary completion: 2008-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.